Microreactor Technology Market Revenue Growth Predicted by 2018 to 2028

Posted by Arslan on July 9th, 2019

In order to dissert the market scenario prevailing across the microreactor technology market sector, FactMR has evenly presented a comprehensive microreactor technology market analysis to its extensive online repository. With all vital market facets enclosed into this single assessment, readers can learn about different market drivers, opportunities and trends which are likely to influence the overall market space for the microreactor technology market in the coming years. In addition, factors such as market size, Y-o-Y growth and revenue share are investigated so as to make this research highly authentic and reliable.

Get a Free Sample Report from Here – https://www.factmr.com/connectus/sample?flag=S&rep_id=2815

Microreactor Technology- Notable Highlights

• Lonza Group AG acquired Micro-Macinazione S.A., a leading provider of micronization services and equipment, in the year 2017.
• Los Alamos National Laboratory, one of the US’ leading nuclear laboratories, developed a new nuclear micro-reactor in 2018 with multipronged applications, ranging from providing electricity in remote areas to powering space missions.
• A cohort of researchers from the University of Helsinki in Finland have developed a 3D printed microreactor device that enables them to gauge chemical reactions effortlessly and to enhance their research processes.
• Researchers from Osaka University in collaboration with Crystal Optics Inc., a prominent manufacturer of plating and polishing products, developed a low-cost manufacturing method of microstructures, including microreactors, by using Water-CARE technology.

This report features key players operating in the microreactor technology market, including Soken Chemical & Engineering Co., Ltd., Bronkhorst (UK) Ltd., Chemtrix B.V., Little Things Factory GmbH, Ehrfeld Mikrotechnik BTS GmbH, Micronit Micro Technologies B.V., AM Technology Co., Ltd., and Vapourtec Ltd.

Tier 3 players hold the hegemony in the microreactor technology market, with a revenue share of nearly 40%. Focus on specific product segments, along with volume sales through the development and maintenance of an adequate product supply, remains one of the primary agendas among the emerging players in the microreactor technology market. . However, higher dependency of tier 3 players on contracts has arrested enhancements in their product portfolios and technological developments.

Meanwhile, the tier 1 players in the microreactor technology market remain focused on novel drug delivery system launches, and strategic alliances with the regional players to extend their market footprint. These players are also oriented toward expansion of manufacturing facilities in regions with significant growth potential, such as India and China, to capitalize on the emerging opportunities.

Potential Benefits over Conventional Processes Bolster Adoption in Chemical Industries

Resurgent growth of chemical industries in the past few years has meant that demand for process intensification to achieve optimal results has also taken off. Microreactor technology has gained widespread acceptance among manufacturers of fine as well as specialty chemicals who seek streamlining their production costs while tackling environmental challenges. Additionally, high compatibility of the microreactor with mixing operations, such as mass transfer and heat transfer, have improved its visibility in the overall chemical industry landscape. Microreactor technology is expected to witness high traction, as it facilitates one-step reactions, while eliminating the risk of alternate reactions, which results in greater polish and higher yields of finished products. Provision of clarity on crucial operational parameters, and enabling seamless process flexibility along with enhanced productivity, are other aspects driving demand for the microreactor tehnology.  Microreactor technology is further expected to continue gain momentum with its greater speed and convenience compared to the conventional processes in various mixing applications.

Reduction of Time-to-Market Aspect Fosters Adoption in Drug Development Processes

Drug development processes in the pharmaceuticals industry are witnessing notable refinements in the internal processes, in line with the evolving market pressures. With the drug development costs being extremely high, key pharmaceutical companies are vying to come up with new products in the market space and enhance research and development throughput. Ability of microreactor technology to decrease time-to-market, which remains one of the highly valued aspects, is empowering its adoption in case of drug development processes. Solid evidences demonstrating higher gains achieved, with reduced development times and enhanced productivity, have necessitated adoption of microreactor technology in the pharmaceutical landscape. Microreactors are set to evolve as a standard tool for pharmacists to achieve production scale-up, which is one of the prominent bottlenecks of a drug development process, along with improved R&D efficiency.